April 16, 2021
ADVAMED SmartBrief
News for medical technology professionalsSIGN UP ⋅   SHARE
Top Story
Siemens Healthineers has completed its $16.4 billion acquisition of Varian Medical Systems. "With the completion of this transaction, we are now best-positioned to take two leaps together: a leap in cancer care and a leap in our impact on healthcare overall," said Siemens Healthineers CEO Bernd Montag.
Full Story: MassDevice (Boston) (4/15) 
LinkedIn Twitter Facebook Email
Business & Market Trends
Robotics technology firm Vicarious Surgical has agreed to merge with special purpose acquisition company D8 Holdings and will go public with an enterprise value of $1.1 billion. "Our robot can see, reach, and work anywhere inside the abdomen, which effectively shrinks the surgeon and puts her/him inside the human body," said Vicarious Surgical co-founder and CEO Adam Sachs.
Full Story: FirstWord HealthTech (4/15),  MassDevice (Boston) (4/15) 
LinkedIn Twitter Facebook Email
Science & Health
Researchers from the University of California at Berkeley have developed a small wireless implant that can give real-time measurements of tissue oxygen levels. The device could be used to monitor the health of transplanted tissues and organs and provide early detection of organ rejection or tissue failure.
Full Story: SlashGear (4/15) 
LinkedIn Twitter Facebook Email
A study presented at the virtual 2021 American Institute of Ultrasound in Medicine annual meeting showed a drop in the total number of ultrasound exams at a New York City hospital over an eight-week period from March to May 2020 to 639, compared with 1,511 during the same time frame in 2019, while the number of patients who had an ultrasound exam and were admitted to the hospital rose from 86 in 2019 to 114 in 2020. Researchers identified several potential reasons for the differences, including fear of the coronavirus, efforts to reduce hospital use among non-COVID-19 patients and health care providers' decisions on whether diagnostic exams were appropriate amid the pandemic.
Full Story: AuntMinnie (free registration) (4/14) 
LinkedIn Twitter Facebook Email
Apple recruiting for early COVID-19 detection study
(Justin Sullivan/Getty Images)
Apple is recruiting volunteers for a study of whether the Apple Watch 6's blood oxygen and heart rate sensors can detect early signs of COVID-19 and other respiratory illnesses, including influenza.
Full Story: TechRadar (4/14) 
LinkedIn Twitter Facebook Email
Emerging Technologies
Researchers from the University of Barcelona have developed a blood test that can identify patients who are at risk of experiencing severe COVID-19 symptoms. The researchers believe the test could become available by October.
Full Story: INews (UK) (4/15) 
LinkedIn Twitter Facebook Email
Government & Regulatory
The FDA has given emergency use authorization to Qorvo for its Omnia SARS-CoV-2 Antigen Test.
Full Story: Seeking Alpha (free registration) (4/15) 
LinkedIn Twitter Facebook Email
European regulators have given CE mark approval to Snibe Diagnostic for its Maglumi HIV Ab/Ag Combi CLIA kit, a fourth-generation chemiluminescence immunoassay that can detect the HIV-1 p24 antigen, as well as HIV-1 and HIV-2 antibodies.
Full Story: 360Dx (tiered subscription model) (4/15) 
LinkedIn Twitter Facebook Email
European regulators have given CE mark approval to Hensler Surgical Technologies for its Hensler Bone Press that is used to harvest autologous material that will be used in bone fusion surgery.
Full Story: Verdict Medical Devices (UK) (4/15) 
LinkedIn Twitter Facebook Email
The FDA has given clearance to Acutus Medical for its AcQCross family of universal transseptal crossing devices.
Full Story: MassDevice (Boston)/Medical Tubing & Extrusion (4/15) 
LinkedIn Twitter Facebook Email
AdvaMed Events and Education
Registration for The Digital MedTech Conference is open! Taking place virtually on May 6, The Digital MedTech Conference is a great opportunity to gain insights from leading industry experts and partake in discussion about current and future challenges, opportunities and trends in the digital health and medical device sectors. Learn more.
LinkedIn Twitter Facebook Email
This annual conference brings together leading authorities from the FDA, industry and academia to address the latest statistical trends and issues facing medtech organizations. In an effort to provide quality programming in the safest and most effective manner possible, the conference will be held virtually this year. New in this year's virtual format, dedicated therapeutic and diagnostic-themed sessions will run on consecutive days, rather than concurrently as in years past. With daily networking receptions and breakout discussions, this conference provides the opportunity to meet and converse with peers, industry leaders, FDA representatives and more while forming lasting connections. Conference registrants who sign up before April 30 will save 15% on their registration fee. Register now.
LinkedIn Twitter Facebook Email
LEARN MORE ABOUT AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
Press ReleasesSponsored Content
  New Data Demonstrate How Cala Trio™ Enables a More Frequent Assessment of Hand Tremor Compared with In-Person Assessments in Patients with Essential Tremor and Supports Feasibility of Telemedicine Approaches for Essential Tremor Management
Post a Press Release
JOBS
  Director of Clinical Research
REGENESIS BIOMEDICAL, INC. - Scottsdale, AZ, US
  Senior Counsel, Regulatory
BECKMAN COULTER LS - Indianapolis, IN, US
View More Listings | Post a Job
Sharing AdvaMed SmartBrief with your network keeps the quality of content high and these newsletters free.
Help Spread the Word
SHARE
Or copy and share your personalized link:
smartbrief.com/advamed/?referrerId=eSriBJbAIQ
When people say, 'You can't teach an old dog new tricks,' it's not true, because you can reinvent yourself and learn new things whenever you want.
Jonathan Van Ness,
hairdresser, actor, writer, TV personality, podcast host
LinkedIn Twitter Facebook Email
SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
Sign Up  |    Update Profile  |    Advertise with SmartBrief
Unsubscribe  |    Privacy policy
CONTACT US: FEEDBACK  |    ADVERTISE
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004